BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23432931)

  • 1. Assessing knowledge and attitudes towards screening among users of Faecal Immunochemical Test (FIT).
    Denters MJ; Deutekom M; Essink-Bot ML; Bossuyt PM; Fockens P; Dekker E
    Health Expect; 2015 Oct; 18(5):839-49. PubMed ID: 23432931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
    van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
    Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of gender on decisions to participate in faecal immunochemical test-based colorectal cancer screening: a qualitative study.
    Clarke N; Gallagher P; Kearney PM; McNamara D; Sharp L
    Psychooncology; 2016 Dec; 25(12):1456-1462. PubMed ID: 26864167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Most participate in faecal immunochemical test-based colorectal cancer screening out of curiosity about their chances of developing cancer.
    Denters MJ; Bossuyt PM; Deutekom M; Fockens P; Dekker E
    Eur J Cancer Prev; 2015 May; 24(3):176-9. PubMed ID: 25734239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Getting adequate information across to colorectal cancer screening subjects can be difficult.
    van Rijn AF; van Rossum LG; Deutekom M; Laheij RJ; Bossuyt PM; Fockens P; Dekker E; Jansen JB
    J Med Screen; 2008; 15(3):149-52. PubMed ID: 18927098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of personalised risk information compared to a positive/negative result on informed choice and intention to undergo colonoscopy following colorectal Cancer screening in Scotland (PERICCS) - a randomised controlled trial: study protocol.
    Steele RJC; Digby J; Chambers JA; O'Carroll RE
    BMC Public Health; 2019 Apr; 19(1):411. PubMed ID: 30991987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The LEAD trial - the effectiveness of a decision aid on decision making among citizens with lower educational attainment who have not participated in FIT-based colorectal cancer screening in Denmark: study protocol for a randomized controlled trial.
    Gabel P; Larsen MB; Kirkegaard P; Edwards A; Andersen B
    Trials; 2018 Oct; 19(1):543. PubMed ID: 30305114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Informed decision-making in colorectal cancer screening using colonoscopy or CT-colonography.
    de Haan MC; de Wijkerslooth TR; Stoop E; Bossuyt P; Fockens P; Thomeer M; Kuipers EJ; Essink-Bot ML; van Leerdam ME; Dekker E; Stoker J
    Patient Educ Couns; 2013 Jun; 91(3):318-25. PubMed ID: 23399437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors Associated with Informed Decisions and Participation in Bowel Cancer Screening among Adults with Lower Education and Literacy.
    Smith SK; Simpson JM; Trevena LJ; McCaffery KJ
    Med Decis Making; 2014 Aug; 34(6):756-72. PubMed ID: 24421292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accessibility of standardized information of a national colorectal cancer screening program for low health literate screening invitees: A mixed method study.
    Fransen MP; Dekker E; Timmermans DRM; Uiters E; Essink-Bot ML
    Patient Educ Couns; 2017 Feb; 100(2):327-336. PubMed ID: 27613567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autonomous and informed decision-making: The case of colorectal cancer screening.
    Douma LN; Uiters E; Verweij MF; Timmermans DRM
    PLoS One; 2020; 15(5):e0233308. PubMed ID: 32469889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Training primary care physicians to offer their patients faecal occult blood testing and colonoscopy for colorectal cancer screening on an equal basis: a pilot intervention with before-after and parallel group surveys.
    Selby K; Cornuz J; Gachoud D; Bulliard JL; Nichita C; Dorta G; Ducros C; Auer R
    BMJ Open; 2016 May; 6(5):e011086. PubMed ID: 27178977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do people with a different goal-orientation or specific focus make different decisions about colorectal cancer-screening participation?
    Douma LN; Uiters E; Timmermans DRM
    PLoS One; 2019; 14(2):e0213003. PubMed ID: 30817788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the choice of colorectal cancer screening tests in primary care settings from 7,845 prospectively collected surveys.
    Wong MC; John GK; Hirai HW; Lam TY; Luk AK; Ching JY; Ng SS; Chan FK; Griffiths SM; Sung JJ
    Cancer Causes Control; 2012 Sep; 23(9):1541-8. PubMed ID: 22836914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge, attitudes and beliefs regarding colorectal cancer screening among ethnic minority groups in the Netherlands - a qualitative study.
    Woudstra AJ; Dekker E; Essink-Bot ML; Suurmond J
    Health Expect; 2016 Dec; 19(6):1312-1323. PubMed ID: 26576015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut-off level on yield of screening.
    Kooyker AI; Toes-Zoutendijk E; Opstal-van Winden AWJ; Spaander MCW; Buskermolen M; van Vuuren HJ; Kuipers EJ; van Kemenade FJ; Ramakers C; Thomeer MGJ; Dekker E; Nagtegaal ID; de Koning HJ; van Leerdam ME; Lansdorp-Vogelaar I
    Int J Cancer; 2020 Aug; 147(4):1098-1106. PubMed ID: 31853977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy.
    Hol L; de Jonge V; van Leerdam ME; van Ballegooijen M; Looman CW; van Vuuren AJ; Reijerink JC; Habbema JD; Essink-Bot ML; Kuipers EJ
    Eur J Cancer; 2010 Jul; 46(11):2059-66. PubMed ID: 20621736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of previous non-participants cannot fully compensate for lower participation in a second round of FIT-screening.
    Denters MJ; Deutekom M; Bossuyt PM; van Rijn AF; Fockens P; Dekker E
    Cancer Epidemiol; 2013 Jun; 37(3):330-5. PubMed ID: 23403127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lifestyle predictors for non-participation and outcome in the second round of faecal immunochemical test in colorectal cancer screening.
    Knudsen MD; Berstad P; Hjartåker A; Gulichsen EH; Hoff G; de Lange T; Bernklev T; Botteri E
    Br J Cancer; 2017 Aug; 117(4):461-469. PubMed ID: 28704841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.